Ieq Capital LLC Makes New $2.85 Million Investment in HealthEquity, Inc. $HQY

Ieq Capital LLC purchased a new position in HealthEquity, Inc. (NASDAQ:HQY) during the 2nd quarter, Holdings Channel reports. The fund purchased 31,528 shares of the company’s stock, valued at approximately $2,848,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Oxbow Advisors LLC bought a new stake in shares of HealthEquity in the 1st quarter valued at about $3,147,000. Maridea Wealth Management LLC purchased a new position in HealthEquity during the second quarter valued at approximately $2,753,000. Deutsche Bank AG bought a new position in HealthEquity in the second quarter worth approximately $11,986,000. Westfield Capital Management Co. LP lifted its holdings in HealthEquity by 13.7% during the fourth quarter. Westfield Capital Management Co. LP now owns 1,952,452 shares of the company’s stock worth $178,864,000 after buying an additional 235,794 shares during the period. Finally, Sumitomo Mitsui DS Asset Management Company Ltd bought a new stake in HealthEquity during the 4th quarter valued at $4,381,000. Institutional investors own 99.55% of the company’s stock.

Insider Activity

In other news, Director Gayle Furgurson Wellborn sold 2,439 shares of the company’s stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $90.00, for a total value of $219,510.00. Following the sale, the director owned 19,733 shares in the company, valued at $1,775,970. This represents a 11.00% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Michael Henry Fiore sold 3,142 shares of the firm’s stock in a transaction dated Friday, May 29th. The stock was sold at an average price of $95.00, for a total value of $298,490.00. Following the sale, the executive vice president directly owned 59,113 shares in the company, valued at approximately $5,615,735. This trade represents a 5.05% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 17,905 shares of company stock valued at $1,651,280 in the last quarter. 1.60% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on the company. KeyCorp reiterated an “overweight” rating on shares of HealthEquity in a research note on Tuesday, May 26th. Barrington Research restated an “outperform” rating and issued a $110.00 price target on shares of HealthEquity in a report on Friday, May 22nd. Weiss Ratings raised shares of HealthEquity from a “hold (c)” rating to a “hold (c+)” rating in a research report on Friday, June 5th. Citizens Jmp increased their target price on shares of HealthEquity from $110.00 to $111.00 and gave the company a “market outperform” rating in a research report on Monday, June 1st. Finally, Citigroup restated a “market outperform” rating on shares of HealthEquity in a research note on Monday, June 1st. Eleven equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $110.93.

HealthEquity Stock Down 0.0%

NASDAQ:HQY opened at $105.40 on Tuesday. The company has a debt-to-equity ratio of 0.46, a current ratio of 3.44 and a quick ratio of 3.44. The company’s fifty day moving average price is $97.01 and its 200-day moving average price is $87.37. HealthEquity, Inc. has a 1-year low of $72.76 and a 1-year high of $107.62. The firm has a market capitalization of $8.81 billion, a P/E ratio of 39.48, a PEG ratio of 1.77 and a beta of 0.21.

HealthEquity (NASDAQ:HQY) last posted its earnings results on Thursday, May 28th. The company reported $1.24 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.11 by $0.13. HealthEquity had a net margin of 17.25% and a return on equity of 14.75%. The company had revenue of $354.64 million during the quarter, compared to the consensus estimate of $352.02 million. HealthEquity’s quarterly revenue was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. As a group, equities research analysts anticipate that HealthEquity, Inc. will post 3.92 EPS for the current year.

HealthEquity Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.